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Abstract 
 
Antimicrobial agents have been in use for therapeutic purposes for over a century, with most of the development 
occurring in the latter half of the twentieth century. Penicillin was the first of the naturally occurring antimicrobials to 
be used in medicine and its structure includes a beta-lactam ring. Further compounds, such as the cephalosporins, were 
discovered and these also included beta-lactam structures. Subsequently bacteria which were resistant to these 
compounds were found, and their resistance was due to their production of enzymes, beta-lactamases, which hydrolysed 
the beta-lactam ring. Synthetic derivatives of the beta-lactam antimicrobials were developed to render them recalcitrant 
to beta-lactamases but enzymes with a broader substrate range evolved, and were categorised as extended substrate 
beta-lactamases (ESBL). Since the antimicrobials had a significant role to play in human medicine the emergence of 
ESBL caused significant concerns. Further, similar antimicrobials were used by veterinarians, raising the prospect that 
bacteria in the commensal flora of livestock could acquire ESBL resistance properties and exchange them via genetic 
exchange. Thus, pathogenic bacteria present in livestock could become resistant to antimicrobials with adverse 
consequences should zoonotic infections occur. In this review we consider the emergence of ESBL, the problems 
involved in detecting and reporting such properties, and consider the consequences for consumers of potentially 
contaminated food products. 
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INTRODUCTION 
 
Therapeutic antimicrobial agents have been 
used in human health care for over a century 
following the discovery of the antisypohilitic 
activity of the synthetic compound 
arsphenamine in 1909. Subsequently a wide 
range of therapeutic compounds was 
discovered, including the penicillins, 
cephalosporins and other naturally occurring 
compounds. The first of the antibiotics to be 
used in medicine was penicillin, synthesised by 
a fungus (Penicillium spp.) and the chemical 
structure of this compound is characterised by 
the presence of a beta-lactam ring. 
Subsequently other beta-lactam antibiotics 
were discovered, such as the cephalosporins. 
The range of beta-lactam like compounds 
available was subsequently expanded by 
further discovery and by chemical modification 
of naturally occurring compounds. 
 
Antimicrobial resistance to beta-lactams 
At present there is a wide range of penicillins, 
cephalosporins, monobactams and 
carbapenems available for therapeutic use. 
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Broadly speaking, all of the compounds act by 
the inhibition of bacterial cell wall biosynthesis 
but may be vulnerable to inactivation due to 
being cleaved by one of the beta-lactamase 
class of enzymes. To maintain the 
antimicrobial activity of the therapeutic agents, 
beta-lactam agents may be combined with 
compounds such as clavulanic acid, which can 
inhibit the activity of some beta-lactamases. 
However, restoring the clinical activity of beta-
lactams is very complex due to the very large 
number of such compounds in use, the small 
number of specific enzyme inhibitors available, 
and large number of beta-lactamase enzymes 
known to exist.  
Beta-lactam antimicrobial agents were widely 
applied in human and animal healthcare but 
resistance to them soon emerged as a clinical 
problem, being reported within two years of 
their widespread use. For several decades new 
beta-lactam agents with enhanced activity were 
regularly developed and introduced, however, 
this stream of new products has slowed, almost 
to a halt, in recent years. The most important 
mechanism conferring bacterial resistance to 
beta-lactam antibiotics is the production of one 
or more enzymes capable of hydrolysing, i.e. 
breaking open, the beta-lactam ring, rendering 
the antibiotic ineffective. In view of their 
properties these enzymes are termed beta-
lactamases. 
In 1965 Datta and Kontomichalou reported in 
Nature that Escherichia coli isolated from a 
patient named Temoneira, in Athens, could 
hydrolyse penicillin due to production of a 
beta-lactamase. The enzyme was designated 
TEM-1, from the patient’s name, and other 
TEM enzymes were discovered in due course 
(Bush et al., 1995). The genes coding for beta-
lactamases were subsequently named by using 
the abbreviation bla with the specific gene type 
being added. In the case above the gene was 
denoted as TEM, hence this group of enzymes 
were referred to as blaTEM. In addition, the 
abbreviation was followed by a number 
denoting the specific enzyme, in the format 
blaTEM-1. The blaTEM genes were found to be 
carried on transposable elements (Blanc et al., 
2006; Partridge and Hall, 2005) i.e. sections of 
DNA, and these elements can be readily 
transferred between members of the 
Enterobacteriaceae (the family of enteric, or 
gut, bacteria to which E. coli belongs) 
(Bradford, 2001; Partridge and Hall, 2005; 
Sirot et al., 1991; Thong and Modarressi, 
2011). Further, transposons are also known to 
be transferred between unrelated species of 
bacteria (Bradford, 2001). 
Less than ten years after TEM-1 was 
discovered a different lactamase enzyme was 
reported, and was later named SHV-1, derived 
from sulfhydryl variable because it was thought 
that the inhibition of SHV activity by p-
chloromercuribenzoate was variable according 
to the substrate used for the assay (Paterson and 
Bonomo, 2005). The beta-lactamase SHV gene 
is denoted blaSHV. Again, numbers are 
appended to the definition to define specific 
enzymes within this group. 
A key feature of the first TEM and SHV 
enzymes was that they hydrolysed penicillins, 
such as ampicillin, but not the newer 
cephalosporin beta-lactams such as cefotaxime. 
Consequently, they can be regarded as having a 
narrow substrate range. Also, they could be 
inhibited by compounds such as clavulanic 
acid, which acts as a competitive inhibitor of 
beta-lactamases. 
 
Emergence of extended spectrum beta-
lactamase (ESBL) 
Third generation cephalosporins (3GC), were 
introduced in the 1980s (Paterson and Bonomo, 
2005) and were also referred to as extended 
spectrum cephalosporins. Due to their efficacy 
they were widely used from the early 1980s 
onward (Bryan, 1991). 
However, soon after the 3GC were introduced 
resistance to them was reported in species such 
as E. coli. The mechanism for this resistance 
was based on beta-lactamase enzymes able to 
hydrolyse a wider (or extended) range of 
substrates than seen previously, including new 
cephalosporins. The term ‘extended spectrum 
beta-lactamase’ was coined (Philippon et al., 
1989) to describe the beta-lactamases 
conferring resistance to 3GC, normally 
abbreviated to ESBL. 
The first ESBLs were seen to be encoded by 
variants of the widely disseminated blaTEM and 
blaSHV genes (Bradford, 2001; Partridge and 
Hall, 2005). Derivatives of the blaTEM and 
blaSHV genes are now numbered in their 
hundreds, and differ subtly in their properties 
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(Bourouis et al., 2015; D'Andrea et al., 2013). 
For most of the 1980s and 1990s these enzymes 
were the main focus of concern in relation to 
ESBLs. 
In Germany Knothe et al. (1983) studied 3GC 
resistant Klebsiella pneumoniae and Serratia 
marcescens, isolated from patients in a 
Frankfurt clinic, and showed that the resistance 
to cefotaxime in K. pneumoniae was plasmid 
based. Further, laboratory studies showed that 
the plasmid in K. pneumoniae was readily 
passed to Escherichia coli, Proteus mirabilis 
and Salmonella typhimurium suggesting that it 
was mobile within the Enterobacteriaceae 
family. The resistance noted in S. marcescens 
was also carried on a plasmid, which could also 
be transferred to the other Enterobacteriaceae 
studied, but some elements were lost in 
transfers to E. coli. The ESBL enzyme was not 
equally efficient in its hydrolysis of 3GC, 
conferring significantly greater resistance to 
cefotaxime than ceftazidime, hence it was 
designated a „cefotaximase” and the gene 
designated blaCTX. The work of Knothe et al. 
(1983) therefore raised the prospect of non-
pathogenic organisms transferring 3GC 
resistance on a plasmid to pathogenic 
organisms, e.g. S. typhimurium. 
Briefly, the history of ESBL enzymes can be 
summarised as progressing from infrequent 
reports of ESBL enzymes, mainly blaTEM and 
blaSHV variants, through to the reporting of 
widespread dissemination of this resistance in 
hospital settings. Early dissemination was 
probably due to a widespread failure of 
authorities to identify this resistance 
phenomenon because of deficiencies in clinical 
laboratory detection procedures. Subsequently 
the blaCTX ESBLs emerged with near 
worldwide dissemination through hospitals 
(Paterson and Bonomo, 2005), nursing homes 
(Rooney et al., 2009), the general community 
and the environment, including food animals 
(Blanc et al., 2006). 
In human healthcare the dissemination of this 
resistance is linked specifically to that of E. 
coli clonal group ST131 (ST indicates DNA 
sequence type) (Clermont et al., 2009) which 
frequently carries this resistance (Morris et al., 
2012; Rooney et al., 2009). More than 10% of 
all E. coli isolated from blood culture in Ireland 
carry ESBL (http://www.hpsc.ie/AboutHPSC/ 
AnnualReports/File,15139,en.pdf).   
 
Antimicrobial resistance in the food chain 
Therapeutic antimicrobial agents were not only 
applied in human medicine, but also in 
veterinary medicine. In addition, antibiotics 
were found to be effective growth promoters, 
especially with poultry, and supplemented 
feeds were used from the 1950s onwards (Jones 
and Ricke, 2003). This later led to concerns 
that antimicrobial resistance (AMR) could 
become widespread in the microflora of 
animals, and subsequently consumers could be 
exposed to these organisms via meats. A 
seminal work in this regard was the UK Report 
on the Use of Antibiotics in Animal Husbandry 
and Veterinary Medicine, aka the Swann 
report, published in 1969 (Soulsby, 2007). 
Others have also highlighted concerns (Bensink 
and Bothmann, 1991), especially the possibility 
of foodborne pathogens, such as Salmonella 
spp., acquiring AMR and compromising 
normal antimicrobial therapy.  
ESBLs have been extensively reported in 
Salmonella enterica where this type of 
resistance significantly complicates the clinical 
management of cases of invasive salmonellosis 
which require systemic treatment. Although 
antimicrobial use in animals is accepted as 
selecting for resistant bacteria in animals, noted 
in the Swann Report, and although it is 
apparent that antimicrobial resistance is found 
in zoonotic pathogens such as Salmonella and 
Campylobacter, there is great uncertainty 
regarding the overall extent to which 
antimicrobial resistance found in human 
isolates can be attributed to antimicrobial use in 
animals (Torneke et al., 2015). One element of 
this uncertainty relates to the extent to which 
antimicrobial resistant E. coli (AREC), and 
other Enterobacteriaceae from the gut of 
animals, are transferred to humans in the food 
chain, and to what extent, if any, this may 
contribute to AMR problems in relation to E. 
coli associated urinary tract infections, blood 
infections and other associated invasive 
infections in people.  
The use of antimicrobials for growth promotion 
in healthy animals was banned by the European 
Union, with effect from 1st January 2006 
(http://europa.eu/rapid/press-release_IP-05-
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1687_en.htm). However, this ban does not 
apply in many other parts of the world which 
export foodstuffs to the EU (Maron et al., 
2013). This was highlighted in late 2015 when 
extensive colistin use in pig production in 
China, led to the associated emergence of 
transferrable colistin resistance in 
Enterobacteriaceae, with subsequent reports of 
worldwide dissemination (Liu et al., 2016). 
Furthermore, antimicrobial agents continue to 
be used in very large quantities for the 
prevention, and treatment, of infection in food 
producing animals. The EU also enforces 
‘washout’ periods following antimicrobial 
administration to animals but it is important to 
note, however, that whilst washout of the 
antimicrobial agents will occur, this does not 
apply to the AMR bacteria, which can be much 
more persistent (Soulsby, 2007). 
In the longer term the removal of 
antimicrobials from use in food animals can 
have benefits: Agersø and Aarestrup (2013) 
reported that a voluntary ban on cephalosporin 
use in Danish pig production had effectively 
reduced the numbers of extended-spectrum 
cephalosporinase-producing Escherichia coli 
detected in slaughter pigs. 
The potential problems arising from antibiotic 
resistant zoonotic infections was addressed by 
the EU over ten years ago, in Zoonosis 
Directive 2003/99/EC, which requires member 
states to undertake monitoring of antimicrobial 
resistance. The document also stated:  
„The alarming emergence of resistance to 
antimicrobial agents (such as antimicrobial 
medicinal products and antimicrobial feed 
additives) is a characteristic that should be 
monitored. Provision should be made for such 
monitoring to cover not only zoonotic agents 
but also, in so far as they present a threat to 
public health, other agents. In particular, the 
monitoring of indicator organisms might be 
appropriate. Such organisms constitute a 
reservoir of resistance genes, which they can 
transfer to pathogenic bacteria.“ 
In consequence both the European Food Safety 
Authority (EFSA) and the European Centre for 
Disease Prevention and Control (ECDC) work 
together to produce an annual report on AMR 
in key zoonotic pathogens isolated in member 
countries from animals and humans: 
Antimicrobial resistance surveillance in Europe 
(Available from 
http://ecdc.europa.eu/en/healthtopics/antimicro
bial_resistance/Pages/publications.aspx). The 
gravity of the problems associated with AMR 
in food animals was further underlined when 
EFSA and ECDC combined with the European 
Medicines Agency (EMA) to produce the 
‘ECDC/EFSA/EMA first joint report on the 
integrated analysis of the consumption of 
antimicrobial agents and occurrence of 
antimicrobial resistance in bacteria from 
humans and food-producing animals’ 
(Available at: http://ecdc.europa.eu/en/ 
publications/Publications/antimicrobial-
resistance-JIACRA-report.pdf). 
The report cited results based on indicator 
organisms which were seen to be carrying 
resistance genes, which could then be passed to 
pathogenic organisms. This is significant since 
traditionally food microbiology sought 
primarily to isolate and identify specific 
pathogenic bacteria from foodstuffs. The 
presence of antimicrobial resistance genes, 
carried on mobile genetic elements which can 
be readily exchanged between members of the 
Enterobacteriaceae, means that the AMR of 
zoonotic bacteria, such as salmonellas, could be 
enhanced by genetic material supplied by other 
Enterobacteriaceae. Hence, should indicator 
organisms carrying a plasmid with an ESBL 
gene be present in the same foodstuff, then 
there is the potential for an ESBL Salmonella 
spp. arising in an infected host (Carattoli, 
2009), which could be resistant to the normal 
therapy.  
 
ESBL E. coli 
E. coli is a very complex heterogeneous species 
of bacteria and a variety of typing methods 
have been used to sub classify members of the 
species. Traditionally phenotypic methods were 
used, such as serotyping (based on O and H 
antigens), phage typing (based on susceptibility 
to panels of bacteriophage) and antibiotic 
resistance patterns. More recently molecular 
methods based on DNA have been developed 
to allow different levels of discrimination 
(Thakur et al., 2010; Leverstein-van Hall et al., 
2011). E. coli is used as an indicator organism, 
since it is ubiquitous in the gastrointestinal tract 
of humans (Sedgley and Samaranayake, 1994) 
and farm animals (Pointon et al., 2012). This 
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ubiquity means that the use of antibiotic 
therapy in animals and humans will expose the 
E. coli of the host to the drugs. It is therefore 
unsurprising that antibiotic resistant E. coli 
have arisen since virtually all cases of 
antibiotic therapy will lead to the host’s gut 
flora being exposed to the agent, with a 
consequent evolutionary pressure to 
develop/acquire drug resistance (Chelariu et al., 
2017). Since E. coli is also a pathogen 
(Schroeder et al., 2003) studies into its drug 
resistance have been undertaken (Bush, 2013; 
Kluytmans et al., 2013) but approaches have 
differed, leading to a lack of consistent data.  
 
Types of ESBL 
Classification schemes to categorise the myriad 
of beta-lactamase enzymes were elaborated 
some decades ago. These classification 
schemes are continuously evolving in the light 
of new discoveries, and have been moved to 
websites accessible online, as have AMR 
definitions (see http://www.eucast.org/). As 
early as 1995 18 types of TEM and 5 types of 
SHV had been described as ESBL (Bush et al., 
1995), but by 2012 more than 1,300 distinct 
beta-lactamase enzymes had been identified 
(Bush, 2013). This proliferation is greatest 
within the TEM and OXA families (Bush, 
2013). OXA lactamases were named for their 
ability to hydrolyze oxacillin. In relation to 
antimicrobial resistance in the food chain, and 
its link with human data, one challenge is that 
many studies of ESBL carrying organisms do 
not fully characterise the ESBL. This is 
illustrated in a review of the antimicrobial 
resistance of emerging foodborne pathogens, 
where Koluman and Dikici (2013) considered 
two Enterobacteriaceae, Salmonella and 
verotoxin producing E. coli, but could not 
indicate the prevalence of ESBL in these 
organisms due to limited information in the 
source material.  
 
Detection of ESBL in foodstuffs 
Studies to determine the presence of ESBL E. 
coli in foods, or in animals destined for 
foodstuffs, have taken many different 
approaches (Mateescu et al., 2014; Sala et al., 
2012). Some of the methods applied for the 
isolation of ESBL E. coli from foodstuffs, or 
livestock, are considered here. Some studies 
investigated E. coli isolates which had been 
obtained as a result of previous surveys or 
statutory analytical work. This approach was 
taken in China (Xia et al., 2011) and Germany 
(Kaesbohrer et al., 2012). Other workers have 
taken samples of foodstuffs and prepared an 
initial suspension which was then directly 
plated onto a selective and diagnostic medium 
from which presumptive E. coli could be 
obtained (Alvarez-Fernandez et al., 2013; 
Chaisatit et al., 2012; Lyhs et al., 2012; 
Schwaiger et al., 2012). The isolates were 
confirmed as E. coli prior to being studied to 
determine their antibiotic resistance, but it 
should be noted that these four studies all used 
different selective media. 
Direct plating has the advantage that organisms 
representative of the total flora will be chosen 
for detailed study, because the isolates selected 
should be those most common in the target 
population. However, should the AREC not be 
the dominant E. coli, then they may not be 
detected. When initial culture is on media 
containing the antimicrobial of interest (e.g. a 
cephalosporin) the intention is to maximise 
detection of such organisms in a sample, in the 
event that they are present as a minority of the 
population, by suppression of susceptible 
organisms which would otherwise mask their 
presence.  
Since the significant property of AREC is their 
resistance to antimicrobials then this property 
can be exploited in the isolation procedures. In 
a study to detect ESBL E. coli in chicken meat 
(Leverstein-van Hall et al., 2011) samples were 
incubated overnight in BPW, then streaked 
onto a commercial diagnostic ESBL medium. 
Mesa et al. (2006) also incubated samples in 
BPW then streaked directly onto a solid 
selective medium, in this case MacConkey agar 
supplemented with 2 mg/l cefotaxime, to 
isolate ESBL E. coli. Egea et al. (2011) used a 
similar BPW recovery incubation, the solid 
selective medium was MacConkey agar 
supplemented with 1 mg/l cefotaxime or 
ceftazidime. Overdevest et al. (2011) applied a 
two-step enrichment when detecting ESBL E. 
coli; samples were incubated overnight in non-
selective broth (in this case tryptone soy broth, 
TSB), then a subculture was placed in TSB 
supplemented with 8 mg/l vancomycin and 
0.25 mg/l cefotaxime before being streaked 
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onto a chromogenic ESBL agar. Thus, a repair 
stage was followed by enrichment of 
presumptive ESBL bacteria which were then 
selected from the diagnostic medium. 
Agersø et al. (2012) combined a selective 
enrichment with a selective diagnostic medium 
to obtain ESBL from meat. Presumptive ESBL-
producing E. coli were isolated by adding the 
meat to MacConkey broth medium 
supplemented with 1 mg/L ceftriaxone. After 
incubation an aliquot was streaked on 
MacConkey agar supplemented with 1 mg/L 
ceftriaxone, incubated overnight at 44°C, and a 
maximum of three colonies were subcultured. 
Costa et al. (2010) adopted a simpler approach 
by only using one medium onto which 
homogenised samples were plated directly. 
Levine agar medium, which is diagnostic for E. 
coli, was used and supplemented with 2 mg/l 
cefotaxime. Growth in the presence of the 
antibiotic indicated presumptive-ESBL 
organisms were present, hence presumptive 
ESBL E. coli could be detected. 
Overall, no single methodology has emerged as 
the most appropriate procedure for isolating 
ESBL E. coli from foodstuffs. Several of the 
studies noted above were designed to 
investigate the total flora of E. coli, and 
characterise representative examples of the 
population. Thus if ESBL comprised a minority 
of the population they might not be detected. 
However, as for any study, the method chosen 
must be fit for the specific purpose of the study 
to be undertaken. Since cost will always be a 
significant factor in research a three step 
process involving repair in a non-selective 
broth, selective enrichment, then detection on a 
diagnostic medium will be at a disadvantage.  
However, the standard procedures for isolating 
Campylobacter spp. from foodstuffs (ISO 
10272-1:2006) are based on a two-step 
procedure: the sample is incubated in a 
selective enrichment broth, i.e. Bolton broth, 
then streaked onto modified charcoal 
cefoperazone deoxycholate agar (mCCDA). It 
should be noted that Bolton broth contains 5 
mg/l cefoperazone, a third-generation 
cephalosporin to which ESBL organisms are 
resistant and mCCDA contains 32 mg/l 
cefoperazone. ESBL E. coli have been reported 
as proliferating during these isolation 
procedures (Jasson et al., 2009; Moran et al., 
2009) despite the fact that both the broth and 
plates are incubated under low oxygen, high 
CO2 conditions at 41°C. This suggests that a 
simplified selection procedure for AREC could 
be based on the use of an enrichment broth 
containing an appropriate antibiotic, and an 
appropriate selective/diagnostic solid medium. 
Confirmation of ESBL 
Whilst study of the isolation procedures used to 
obtain ESBL E. coli shows that a wide range of 
methodologies have been applied, the 
characterisation of the antimicrobial resistance 
of these organisms is more consistent. This is 
due to the fact that standard procedures for 
determining the antimicrobial susceptibility of 
bacteria have been developed for use in 
medicine. The Clinical and Laboratory 
Standards Institute (CLSI) has promulgated 
standardised methods to determine 
antimicrobial resistance (AMR). Nowadays, 
however, in Europe the methods and 
interpretive criteria of the European Committee 
on Antimicrobial Susceptibility Testing 
(EUCAST; http://www.eucast.org) is the most 
widely accepted approach and it informs the 
joint EFSA/ECDC summary report. Following 
revisions in interpretive criteria in recent years 
there is now very close agreement between 
CLSI and EUCAST in relation to antimicrobial 
susceptibility testing of E. coli and methods for 
confirming ESBL production in E. coli. 
The use of CLSI defined methodologies to 
detect AMR is seen to be relatively common, 
Table 1. Disc diffusion was applied in 38% of 
cases whilst automated broth dilution systems 
were used in 25% of cases, i.e. Agersø et al. 
(2012) (Cook et al., 2011), Xia et al. (2011) 
and Zhao et al. (2012). Since disc diffusion 
analysis can be undertaken with minimal 
equipment, and hence capital costs, its more 
frequent use is not unexpected. Specific discs 
which combine amoxicillin with clavulanate 
were commonly applied to allow the 
confirmation of ESBL. Clavulanate inhibits 
ESBL and therefore increased sensitivity to 
amoxicillin should then be observed, in 
comparison to exposure to amoxicillin alone, if 
ESBL is present.  This effect can also be 
observed using other methodologies noted for 
the AMR test (Table 1). It is important to note 
that the AMR tests, and ESBL confirmation 
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methods, listed in Table 1 are indicative of the 
work undertaken and not exhaustive.  
When E. coli are confirmed as producing ESBL 
then further studies to define the specific type 
of beta-lactamase may be undertaken. 
However, this cannot be done by phenotyping, 
due to the very similar properties of some 
ESBL, and DNA-based studies are required.  
Characterisation of ESBL 
The costs of the work required to define 
precisely which ESBL is being produced by an 
organism is significant, and it should be noted 
that only 25% of the studies listed in Table 1 
undertook this task, even in part.  
This is due to the diversity of the enzymes 
within each group. Using DNA amplification, it 
is possible to differentiate between the main 
groups: blaTEM, blaSHV and blaCTX-M, and to 
some degree differentiate within the subgroups, 
e.g. blaCTX-M groups 1-9 but DNA sequencing 
of their genomes is often required to 
specifically differentiate them. Working with 
E. coli isolated from eggs, Egea et al. (2011) 
used specific primers to identify ESBL as 
belonging to the CTX-M-9, SHV and CTX-M-
1 groups.  
 
Table 1. Methods used to define the antimicrobial 
resistance (AMR) of Escherichia coli isolates obtained 
from foodstuffs. Where Clinical and Laboratory 
Standards Institute (CLSI) methodology was specifically 
mentioned in the article this is denoted by +. The E-test 
is a commercial product to determine AMR, sold by 
bioMérieux 
Reference AMR 
test 
CLSI ESBL 
confirmation 
Agersø et al., 2012 Broth + Am/clav4, 
discs, PCR, 
microarray, 
sequencing  
Alvarez-Fernandez 
et al., 2013 
Disc1 + Am/clav 
Chaisatit et al., 
2012 
Disc + Am/clav 
Cook et al., 2011 Broth2  Am/clav 
Costa et al., 2010 Disc + Am/clav 
Egea et al., 2011   
PCR, 
sequencing 
Kaesbohrer et al., 
2012 
Broth  + 
Implicit in 
AMR results 
Leverstein-van 
Hall et al., 2011 
Previous 
studies 
 Microarray 
Lyhs et al., 2012 Disc  Am/clav 
Mesa et al., 2006 Disc + E-test 
Obeng et al., 2012 Agar2  + E-test 
Overdevest et al., 
2011 
Chromo
genic 
agar 
 
E-test, 
dHPLC5, 
microarray, 
sequencing 
Schwaiger et al., 
2012 
Broth   Am/clav 
Shahada et al., 
2013 
Disc + PCR 
Xia et al., 2011 Broth  + Am/clav 
Zhao et al., 2012 Broth   Am/clav 
1Disc diffusion, 2Broth dilution, 3Agar dilution. 
4Amoxicillin+clavulanate, 5denaturing high performance liquid 
chromatography. 
The amplicons produced by the primers were 
then sequenced to more narrowly define the 
ESBL. Shahada et al. (2013) isolated 
Salmonella spp. and E. coli from broilers, then 
used ten primer pairs to identify ESBL as 
TEM, TEM-52, SHV, CMY-2 or one of six 
CTX groups. For the latter groups, organisms 
carrying the genes blaTEM, blaCTX-M-1,           
blaCTX-M-2, and blaCTX-M-9 were identified using 
primers that amplified a partial sequence of the 
target genes in the initial screening. Specific 
primers to amplify the entire sequence of the 
target genes were then used to obtain 
amplicons for the DNA sequencing analysis. 
Thus the identification of specific ESBL 
requires sophisticated technology, and 
ultimately is based on DNA sequencing. Some 
of the different approaches which can be 
applied to the identification of ESBL are 
illustrated in the study of Overdevest et al. 
(2011) where all E. coli isolates were tested for 
blaCTX-M by using PCR (with amplicons being 
identified using denaturing high-performance 
liquid chromatography), then screened for other 
ESBL genes by using a micro-array test that 
was designed to detect single nucleotide 
polymorphisms in essential blaTEM and blaSHV 
genes, variant genes, and blaCTX-M group genes 
(blaCTX-M-1, blaCTX-M-2, blaCTX-M-9, and         
blaCTX-M-8/25). On the basis of microarray 
results, organisms carrying blaSHV, blaTEM, and 
blaCTX-M genes were identified and the genes 
amplified using specific primers and PCR. PCR 
amplicons were then selected and sequenced 
after purification. 
Agersø et al. (2012) also used microarray, 
PCR, and sequencing technology, but initially 
genotyped their E. coli isolates into two groups 
based on AMR. Two ESBL phenotypes were 
commonly found in the reservoirs studied (pigs 
and pork) and isolates were characterised as 
one of these: ESBLM (resistant to cefoxitin and 
cefepime), and ESBLA (resistant to cefoxitins 
and reduced in susceptibility to cefepime; 
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resistance to ceftazidime and/or cefotaxime and 
synergy to clavulanic acid) or unclear 
interpretation. ESBLM isolates were first 
screened for blaCMY-2 by PCR and sequencing; 
if negative, the isolates were further screened 
for up-regulated ampC by PCR and 
sequencing. The rest of the ESBLMs were 
screened using two different microtube DNA 
array systems and based on the array result, 
PCR and sequencing were done. ESBLA 
isolates were screened for blaCTX-M by PCR and 
further sequenced for determination of the 
blaCTX-M type. If the isolates were negative for 
blaCTX-M, they were screened for blaTEM and 
blaSHV by PCR followed by sequencing. 
Isolates negative for these two PCRs were 
examined by DNA array and, based on the 
result, PCR and sequencing were done to 
determine the exact gene responsible for 
resistance to cephalosporins. Isolates with an 
unclear phenotype were screened for up-
regulation of the ampC gene and for the 
presence of blaCTX-M genes. For isolates 
negative for up-regulated ampC or blaCTX-M 
genes, the DNA array system was used 
followed by PCR and sequencing. 
Agersø et al. (2012) recommended that 
standard surveillance methods should be 
supplemented with methods based on selective 
enrichment when monitoring ESBLs. They also 
noted that the detection of ESBL genotypes in 
pigs or broiler meat which were also found in 
humans indicated that food-producing animals 
may be the origin, in at least part, of human 
cases. Hence information on ESBL genotype 
may be valuable for source attribution. 
It is of interest to note that when Shahada et al., 
(2013) studied the distribution of ESBL in 
Salmonella and E. coli isolated from broilers in 
Japan, they found three groups: TEM, SHV and 
CTX, but they also screened for seven plasmids 
associated with ESBL (IncP, IncI1-Iy, IncFIB, 
IncFIC, IncK, IncB/O and IncY). Thus, the 
phenotypic property was defined, but also the 
genotypic means of dissemination was 
identified.  
From the studies of (Agersø et al., 2012 and 
Overdevest et al., 2011) reported above, in a 
simplified fashion, it can be seen that the 
identification of ESBL is complex and requires 
considerable resources. Once phenotyping has 
confirmed the presence of ESBL then 
genotyping, in some form or another, will be 
required to identify the specific ESBL. Such an 
identification may be to the level of group, i.e. 
TEM, SHV or CTX, or continue to the 
identification of the precise gene carried by the 
organism, such as blaCTX-M-1. In view of the 
costs and complexity of the procedures 
involved, detailed characterisation of ESBL is 
unlikely to be commonly undertaken until 
inexpensive tools are available. A consequence 
of this is to limit the number of studies 
providing detailed information on ESBL 
isolated. Further, it is important to define the 
transferable DNA element carrying the 
resistance gene, in order to fully understand the 
risk posed by the bacterial host, and be able to 
attribute its source. 
Determining that E. coli carrying ESBL are 
present in foodstuffs does not in itself confirm 
a risk to people. The potential for such foods to 
act as vectors and carry the resistant bacteria, in 
a viable state, to humans where they cause 
infection must be determined. Even if the        
E. coli is unable to colonise transference of 
resistance to the resident gut flora must be 
considered. Hence detailed characterisation of 
both foodborne and human E. coli with ESBL 
must be undertaken, in order to allow 
comparison. The study of (Leverstein-van Hall 
et al., 2011) undertook such a comparison and 
concluded that their findings were suggestive 
for transmission of ESBL genes, plasmids and 
E. coli isolates from poultry to humans, most 
likely through the food chain. 
 
Tracing the appearance of foodborne ESBL 
E. coli 
The evolution of an organism and its ability to 
proliferate or persist in certain environments 
can normally be discovered by reviewing the 
literature relevant to the specific organism. For 
example, Franz and van Bruggen (2008) 
reviewed the ecology of E. coli O157:H7 and 
Salmonella enterica in the primary vegetable 
production chain. In principle, this would 
require a literature search to find publications 
in which the target organisms were associated 
with the vegetable production chain. However, 
E. coli O157:H7 is a specific sub-group with a 
species whilst most of the pathogenic 
salmonellas considered were also subspecies: 
Salmonella enterica subsp. enterica. In marked 
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contrast to obtaining studies of specific 
bacterial groups in a given environment, the 
study of ESBL is a study of the property of 
specific antibiotic resistance due to the ability 
of bacteria to produce enzymes. The genes for 
these enzymes may be on plasmids (Shahada et 
al., 2013) or transposable elements (Partridge 
and Hall, 2005). As noted above, studies can 
vary widely in terms of the information 
reported on ESBL, which may be produced by 
a wide range of different species, and genera. 
For example, Taguchi et al. (2012) simply 
reported the prevalence of ESBL and AmpC 
phenotypes of Salmonella enterica, collected 
from retail chicken over a five year period, 
whilst Mateescu et al. (2014) studied both          
E. coli and S. enterica.  
Also, as new ESBL enzymes arose the 
nomenclature was changed (Bush et al., 1995), 
hence synonyms exist for some enzymes, 
complicating the search for specific ESBLs. 
Overall, the history of foodborne ESBL is 
complicated by the restrictions under which 
studies were undertaken, often leading to 
relatively limited information on the type of 
ESBL being published. 
 
Foodborne infections 
As noted above, the confirmation of zoonotic 
transfer requires that both the E. coli genotype, 
and the specific ESBL enzyme(s) must be 
confirmed as occurring both in animals and 
people. This imposes a high burden of proof, 
requiring more detailed research (Young et al., 
2009) and few examples exist in the literature. 
However, such infections have been suggested 
as possible by several studies (Jakobsen et al., 
2011; Jakobsen et al., 2010; Lyhs et al., 2012; 
Obeng et al., 2012). Further, carriage of such 
antimicrobial resistance will compromise 
treatment of the animals themselves (Olsen et 
al., 2014), and the elimination of ESBL would 
benefit animals as well as reducing the 
possibility of zoonotic infection. 
Whilst data from previous studies indicates 
similarities between ESBL in animals and man, 
the transmission routes have yet to be defined 
(Sharp et al., 2014). However, the subject is of 
great significance with the UK Government 
producing a report in 2015: „Antimicrobials in 
agriculture and the environment: reducing 
unnecessary use and waste“ (Available at 
http://amr-review.org) indicating that the 
potential for zoonotic infections must be 
addressed. Amongst other conclusions the 
report noted that ‘countries need to come 
together and agree to restrict, or even ban, the 
use of antibiotics in animals that are important 
for humans. Hence zoonotic transfers are 
considered probable, and in 2015 a Food Safety 
Authority of Ireland report (available at 
https://www.fsai.ie/publications_AMR)  
concluded that ‘use of antimicrobials in food 
production and the potential for spread of 
bacteria from host-to-host through the food 
chain are areas of concern. 
Hence the potential for foodborne infections is 
accepted as a threat, but the complex nature of 
the routes of transmission, and the manner in 
which both the bacteria, and the resistance 
elements, require characterisation at the 
molecular level to allow identification has 
limited progress in this field. However, the 
rapid strides made in DNA sequencing 
technology mean that whole genome 
sequencing can provide definitive information 
on bacteria, which could be used to track 
resistant strains (Koser et al., 2014). Relating 
sequence data to phylogenetic properties of 
pathogens has been described (Gordon et al., 
2014; Tyson et al., 2015; Zhang et al., 2015) 
Thus the tools to define the types of zoonotic 
transfer which can occur, and therefore allow 
the risks to be assessed, are available and it 
remains for appropriate studies to be 
undertaken to allow the risks posed by 
antimicrobial resistant E. coli in foodstuffs to 
be defined. 
Overall, in the preparation of this review 
almost all of the scientific articles referring to 
the study of antimicrobial resistance in 
foodstuffs contained terms referring to meats. 
Thus, there has been a preponderance of study 
on potential zoonotic transfers.  
Milk was only cited in two articles, as a source 
of antimicrobial resistant bacteria. Thus the 
majority of antimicrobial resistant bacteria are 
associated with the meats of chicken, beef and 
pork, and these were the subject of study in the 
study of retail meats on retail sale on the island 
of Ireland, in the project of which this report is 
a part. However, salads have yielded AREC 
(Egea et al., 2011), and, as noted above, (Franz 
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and van Bruggen, 2008) vegetables can be 
vectors for pathogenic Enterobacteriaceae.  
 
CONCLUSIONS 
 
Since people are homoeothermic, then bacteria 
which can colonise them must be mesophilic, 
and such organisms are normally found 
associated with other homoeothermic animals, 
such as those farmed to provide meats. The use 
of antibiotics in animal husbandry will be one 
of the factors leading to antimicrobial resistant 
bacteria being present on, or in, food animals. 
During the slaughter of these animals the 
bacteria can be transferred to edible products, 
and subsequently obtain access to the 
consumers homes. There is also the possibility 
of direct transfer of such organisms to those 
involved in farming, slaughtering, and 
processing such animals (Sharp et al., 2014).  
Although Escherichia coli is considered 
ubiquitous, isolates from different meats are 
seen to have different phenotypes (Johnson et 
al., 2009). Thus demonstrating a zoonotic 
infection in people requires a detailed 
knowledge of E. coli from people, and food 
animals. Given advances in the sequencing 
entire bacterial genomes this will be possible. 
Further, the specific mechanisms which confer 
antimicrobial resistance properties are many 
and varied, as discussed above, but these can be 
defined using whole genome sequencing. Thus 
the risks posed to people by foodborne bacteria 
carrying antimicrobial resistance factors will be 
ultimately defined, given sufficient study. 
Currently, however, there is a need to define 
the prevalence of organisms such as ESBL        
E. coli in retail meats and other foodstuffs, and 
undertake characterisation of the bacterial 
phenotype, and define, as far as resources will 
allow, the type of ESBL carried. Such study 
will allow more detailed future work to be 
targeted at the E. coli which appear to 
constitute the greatest risk to the human 
population. This in turn will allow prophylactic 
measures to be aimed at the foodstuffs of 
greatest concern. 
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